The Journal of Pain
Volume 12, Issue 3 , Pages 315-322 , March 2011

The Antinociceptive Effects of AR-A014418, a Selective Inhibitor of Glycogen Synthase Kinase-3 Beta, in Mice

  • Daniel F. Martins

      Affiliations

    • Departamento de Ciências Fisiológicas, Universidade Federal de Santa Catarina, Florianópolis, Brazil
    • ,
  • Angelo O. Rosa

      Affiliations

    • Instituto Teófilo Hernando, Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain
    • ,
  • Vinícius M. Gadotti

      Affiliations

    • Departamento de Ciências Fisiológicas, Universidade Federal de Santa Catarina, Florianópolis, Brazil
    • ,
  • Leidiane Mazzardo-Martins

      Affiliations

    • Departamento de Ciências Fisiológicas, Universidade Federal de Santa Catarina, Florianópolis, Brazil
    • ,
  • Francisney P. Nascimento

      Affiliations

    • Departamento de Ciências Fisiológicas, Universidade Federal de Santa Catarina, Florianópolis, Brazil
    • ,
  • Javier Egea

      Affiliations

    • Instituto Teófilo Hernando, Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain
    • ,
  • Manuela G. López

      Affiliations

    • Instituto Teófilo Hernando, Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain
    • ,
  • Adair R.S. Santos

      Affiliations

    • Departamento de Ciências Fisiológicas, Universidade Federal de Santa Catarina, Florianópolis, Brazil
    • Corresponding Author InformationAddress reprint requests to Dr. Adair R. S. Santos, Department of Physiological Sciences, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.

Received 27 April 2009 ,Revised 2 June 2010 ,Accepted 15 June 2010.

References 

  1. Bao Z, Lim S, Liao W, Lin Y, Thiemermann C, Leung BP, et al. Glycogen synthase kinase-3beta inhibition attenuates asthma in mice. Am J Respir Crit Care Med. 2007;176:431–438
  2. Bleakman D, Alt A, Nisenbaum ES. Glutamate receptors and pain. Semin Cell Dev Biol. 2006;17:592–604
  3. Bhat R, Xue Y, Berg S, Hellberg S, Ormo M, Nilsson Y, et al. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J Biol Chem. 2003;278:45937–45945
  4. Chen P, Gu Z, Liu W, Yan Z. Glycogen synthase kinase 3 regulates N-methyl-D-aspartate receptor channel trafficking and function in cortical neurons. Mol Pharmacol. 2007;72:40–51
  5. Choi SS, Han KJ, Lee JK, Lee HK, Han EJ, Kim DH, et al. Antinociceptive mechanisms of orally administered decursinol in the mouse. Life Sci. 2003;73:471–485
  6. Cuzzocrea S, Genovese T, Mazzon E, Esposito E, Muia C, Abdelrahman M, et al. Glycogen synthase kinase-3beta inhibition attenuates the development of bleomycin-induced lung injury. Int J Immunopathol Pharmacol. 2007;20:619–630
  7. Cuzzocrea S, Mazzon E, Di Paola R, Muia C, Crisafulli C, Dugo L, et al. Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse. Clin Immunol. 2006;120:57–67
  8. Dugo L, Abdelrahman M, Murch O, Mazzon E, Cuzzocrea S, Thiemermann C. Glycogen synthase kinase-3beta inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation. Shock. 2006;25:485–491
  9. Embi N, Rylatt DB, Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem. 1980;107:519–527
  10. Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J. 2001;359:1–16
  11. Gadotti VM, Tibola D, Paszcuk AF, Rodrigues AL, Calixto JB, Santos ARS. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice. Brain Res. 2006;1093:116–122
  12. Grimes CA, Jope RS. CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem. 2001;78:1219–1232
  13. Hemmings BA, Yellowlees D, Kernohan JC, Cohen P. Purification of glycogen synthase kinase 3 from rabbit skeletal muscle. Copurification with the activating factor (FA) of the (Mg-ATP) dependent protein phosphatase. Eur J Biochem. 1981;119:443–451
  14. Hunskaar S, Fasmer OB, Hole K. Formalin test in mice, a useful technique for evaluating mild analgesics. J Neurosci Methods. 1985;14:69–76
  15. Hunskaar S, Hole K. The formalin test in mice: Dissociation between inflammatory and non-inflammatory pain. Pain. 1987;30:103–114
  16. Jope RS, Roh MS. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets. 2006;7:1421–1434
  17. Jope RS, Yuskaitis CJ, Beurel E. Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics. Neurochem Res. 2007;32:577–595
  18. Kelly S, Zhao H, Hua Sun G, Cheng D, Qiao Y, Luo J, et al. Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia. Exp Neurol. 2004;188:378–386
  19. Kleinschnitz C, Brinkhoff J, Zelenka M, Sommer C, Stoll G. The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J Neuroimmunol. 2004;149:77–83
  20. Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev. 2001;53:597–652
  21. Martin M, Rehani K, Jope RS, Michalek SM. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol. 2005;6:777–784
  22. Millan MJ. The induction of pain: An integrative review. Prog Neurobiol. 1999;57:161–164
  23. Neugebauer V. Metabotropic glutamate receptors: Important modulators of nociception and pain behavior. Pain. 2002;98:1–8
  24. Niswender CM, Conn PJ. Metabotropic glutamate receptors: Physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol. 2010;50:295–322
  25. Parkitna JR, Obara I, Wawrzczak-Bargiela A, Makuch W, Przewlocka B, Przewlocki R. Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats. J Pharmacol Exp Ther. 2006;319:832–839
  26. Robertson SA, Mau VJ, Hudson SN, Tremellen KP. Cytokine-leukocyte networks and the establishment of pregnancy. Am J Reprod Immunol. 1997;37:438–442
  27. Rosa KA, Gadotti VM, Rosa AO, Rodrigues AL, Calixto JB, Santos ARS. Evidence for the involvement of glutamatergic system in the antinociceptive effect of ascorbic acid. Neurosci Lett. 2005;381:185–188
  28. Rylatt DB, Aitken A, Bilham T, Condon GD, Embi N, Cohen P. Glycogen synthase from rabbit skeletal muscle. Amino acid sequence at the sites phosphorylated by glycogen synthase kinase-3, and extension of the N-terminal sequence containing the site phosphorylated by phosphorylase kinase. Eur J Biochem. 1980;107:529–537
  29. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol. 1995;115:1265–1275
  30. Salazar M, Rojo AI, Velasco D, de Sagarra RM, Cuadrado A. Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem. 2006;281:14841–14851
  31. Santos ARS, Vedana EMA, De Freitas GAG. Antinociceptive effect of meloxicam, in neurogenic and inflammatory nociceptive models in mice. Inflamm Res. 1998;47:302–307
  32. Santos ARS, Gadotti VM, Oliveira GL, Tibola D, Paszcuk AF, Neto A, et al. Mechanisms involved in the antinociception caused by agmatine in mice. Neuropharmacology. 2005;48:1021–1034
  33. Tadano T, Namioka M, Nakagawasai O, Tan-No K, Matsushima K, Endo Y, et al. Induction of nociceptive responses by intrathecal injection of interleukin-1 in mice. Life Sci. 1999;65:255–261
  34. Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: An evaluation of the method. Pain. 1992;51:5–17
  35. Wang H, Garcia CA, Rehani K, Cekic C, Alard P, Kinane DF, et al. IFN-beta production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-beta. J Immunol. 2008;181:6797–6802
  36. Whittle BJ, Varga C, Pósa A, Molnár A, Collin M, Thiemermann C. Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta. Br J Pharmacol. 2006;147:575–582
  37. Woodgett JR. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 1990;9:2431–2438
  38. Yuskaitis CJ, Jope RS. Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cell Signal. 2009;21:264–273
  39. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–110

 Supported by grants from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Apoio à Pesquisa Científica Tecnológica do Estado de Santa Catarina (FAPESC), Financiadora de Estudos e Projetos (FINEP, Rede Instituto Brasileiro de Neurociência (IBN-Net, ref. 01.06.0842-00), Brazil), and the Spanish Ministry of Science and Innovation (Ref. SAF2006-08540 and Ref. PHB2007-0004-PC; Programa hispano-brasileño de cooperación interuniversitaria) awarded to M.G.L.

PII: S1526-5900(10)00581-X

doi: 10.1016/j.jpain.2010.06.007

The Journal of Pain
Volume 12, Issue 3 , Pages 315-322 , March 2011

Article Tools

* Image Usage & Resolution